 |
|
 |
|
|
 |
|||
       |
|||
|
|||
 |
|||
|
|||
Segment Results - 4 th Quarter Fiscal Year 2011
(in thousands of $’s, except
per share data)
| Fiscal 2010 | Increase (Decrease) From Fiscal 2009 | ||||||||||
| First Quarter |
Second Quarter |
Third Quarter |
Fourth Quarter |
YTD | Percent Of Sales |
First Quarter |
Second Quarter |
Third Quarter |
Fourth Quarter |
YTD | |
| Sales | 67,945 | 67,708 | 76,271 | 78,038 | 289,962 | 100% | 1,411 | 2,187 | 5,993 | 11,324 | 20,915 |
| Cost of sales | 15,350 | 15,327 | 15,941 | 18,407 | 65,025 | 22% | 2,340 | 1,889 | 1,434 | 4,464 | 10,127 |
| Gross margin | 52,595 | 52,381 | 60,330 | 59,631 | 224,937 | 78% | (929) | 298 | 4,559 | 6,860 | 10,788 |
| Gross margin percentage | 77.40% | 77.40% | 79.10% | 76.40% | 77.60% | ||||||
| SG&A expense | 7,613 | 8,427 | 9,295 | 10,562 | 35,897 | 12% | (556) | (711) | 1,497 | 2,967 | 3,197 |
| R&D expense | 6,619 | 6,603 | 6,297 | 6,466 | 25,985 | 9% | 465 | 212 | (28) | 215 | 864 |
| Interest income | (847) | (1,020) | (1,067) | (818) | (3,752) | (1%) | 321 | 136 | (27) | 193 | 623 |
| Other non-operating ex., net | 257 | 698 | 421 | 450 | 1,826 | 1% | (405) | (313) | (828) | (885) | (2,431) |
| 13,642 | 14,708 | 14,946 | 16,660 | 59,956 | 21% | (175) | (676) | 614 | 2,490 | 2,253 | |
| Earnings before income taxes | 38,953 | 37,673 | 45,384 | 42,971 | 164,981 | 57% | (754) | 974 | 3,945 | 4,370 | 8,535 |
| Income taxes | 12,580 | 11,139 | 14,320 | 14,640 | 52,679 | 18% | (355) | (839) | 5,269 | 1,933 | 6,008 |
| 26,373 | 26,534 | 31,064 | 28,331 | 112,302 | 39% | (399) | 1,813 | (1,324) | 2,437 | 2,527 | |
| Diluted earnings per share | 0.71 | 0.71 | 0.84 | 0.76 | 3.02 | ||||||
| Weighted average diluted shares outstanding | 37,107 | 37,156 | 37,194 | 37,230 | 37,172 | ||||||
Back to Top
(in thousands of $’s)
| Fiscal 2010 | Increase (Decrease) From Fiscal 2009 | ||||||||||
| First Quarter |
Second Quarter |
Third Quarter |
Fourth Quarter |
YTD | Percent Of Sales |
First Quarter |
Second Quarter |
Third Quarter |
Fourth Quarter |
YTD | |
| Sales | 4,904 | 4,628 | 5,151 | 4,992 | 19,675 | 100% | 236 | 303 | 213 | 529 | 1,281 |
| Cost of sales | 2,509 | 2,707 | 2,642 | 2,578 | 10,436 | 53% | 190 | 415 | 137 | 75 | 817 |
| Gross margin | 2,395 | 1,921 | 2,509 | 2,414 | 9,239 | 47% | 46 | (112) | 76 | 454 | 464 |
| Gross margin percentage | 48.80% | 41.50% | 48.70% | 48.40% | 47.00% | ||||||
| SG&A expense | 328 | 336 | 438 | 349 | 1,451 | 7% | (42) | (30) | 92 | 38 | 58 |
| R&D expense | 198 | 224 | 193 | 194 | 809 | 4% | -- | 23 | (5) | 1 | 19 |
| Interest income | (53) | (66) | (69) | (55) | (243) | (1%) | 19 | 6 | (4) | 13 | 34 |
| 473 | 494 | 562 | 488 | 2,017 | 10% | (23) | (1) | 83 | 52 | 111 | |
| Pretax result | 1,922 | 1,427 | 1,947 | 1,926 | 7,222 | 37% | 69 | (111) | (7) | 402 | 353 |
Back to Top
(in thousands of $’s)
| Fiscal 2010 | Increase (Decrease) From Fiscal 2009 | ||||||||||
| First Quarter |
Second Quarter |
Third Quarter |
Fourth Quarter |
YTD | Percent Of Sales |
First Quarter |
Second Quarter |
Third Quarter |
Fourth Quarter |
YTD | |
| Sales | 63,041 | 63,080 | 71,120 | 73,046 | 270,287 | 100% | 1,175 | 1,884 | 5,780 | 10,795 | 19,634 |
| Cost of sales | 12,841 | 12,620 | 13,299 | 15,829 | 54,589 | 20% | 2,150 | 1,474 | 1,297 | 4,389 | 9,310 |
| Gross margin | 50,200 | 50,460 | 57,821 | 57,217 | 215,698 | 80% | (975) | 410 | 4,483 | 6,406 | 10,324 |
| Gross margin percentage | 79.60% | 80.00% | 81.30% | 78.30% | 79.80% | ||||||
| SG&A expense | 6,486 | 6,859 | 7,926 | 8,787 | 30,058 | 11% | (331) | (487) | 1,202 | 2,163 | 2,547 |
| R&D expense | 6,421 | 6,379 | 6,104 | 6,272 | 25,176 | 9% | 465 | 189 | (23) | 214 | 845 |
| Interest income | (662) | (818) | (871) | (673) | (3,024) | (1%) | 252 | 82 | (57) | 117 | 394 |
| Exchange loss/gain | (505) | 87 | (249) | (177) | (844) | -- | (362) | (13) | (621) | (808) | (1,804) |
| 11,740 | 12,507 | 12,910 | 14,209 | 51,366 | 19% | 24 | (229) | 501 | 1,686 | 1,982 | |
| Pretax result | 38,460 | 37,953 | 44,911 | 43,008 | 164,332 | 61% | (999) | 639 | 3,982 | 4,720 | 8,342 |
(1) Includes R&D Systems' Biotechnology Division, R&D Systems Europe, BiosPacific, R&D China, Boston Biochem and Tocris.
Back to Top
(in thousands of $’s)
| Fiscal 2010 | Increase (Decrease) From Fiscal 2009 | |||||||||
| First Quarter |
Second Quarter |
Third Quarter |
Fourth Quarter |
YTD | First Quarter |
Second Quarter |
Third Quarter |
Fourth Quarter |
YTD | |
| Interest income | 132 | 136 | 127 | 90 | 485 | (50) | (48) | (34) | (63) | (195) |
| Rental income | 123 | 138 | 114 | 174 | 549 | 42 | 23 | 31 | 40 | 136 |
| 255 | 274 | 241 | 264 | 1,034 | (8) | (25) | (3) | (23) | (59) | |
| SG&A expense | 799 | 1,232 | 931 | 1,426 | 4,388 | (183) | (194) | 203 | 766 | 592 |
| Other-Building expenses | 556 | 531 | 586 | 620 | 2,293 | 8 | 1 | (7) | 91 | 93 |
| Other-Equity Investment losses | 329 | 218 | 198 | 181 | 926 | (9) | (278) | (169) | (128) | (584) |
| 1,684 | 1,981 | 1,715 | 2,227 | 7,607 | (184) | (471) | 27 | 729 | 101 | |
| Pretax result | (1,429) | (1,707) | (1,474) | (1,963) | (6,573) | 176 | 446 | (30) | (752) | (160) |
(2) Unallocated corporate expenses and Techne’s share of losses by Hemerus Medical, LLC and Nephromics, LLC.
Back to Top
|
Home -
Company News -
Financial Information -
About TECHNE -
Map/Directions -
Products -
Contact Us
TECHNE CORPORATION 614 McKinley Place N.E. Minneapolis, MN 55413-2610 Phone: (612)379-8854 Fax: (612)379-6580 e-mail: techinfo@techne-corp.com * Up to a 15 minute delay on Market Overview. Please consult your financial advisor for an up-to-minute quote. Quote provided by Barchart.com. |